Showing 121-130 of 3001 results for "".
Monoclonal Antibody Studies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/monoclonal-antibody-studies/30233/An Interview with Rachelle S. Doody, MD, PhDEpilepsy and Cognition
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/epilepsy-and-cognition/31717/An Interview with Barbara C. Jobst, MDBotox for Chronic Migraine: Tips and Tricks
https://practicalneurology.com/diseases-diagnoses/headache-pain/botox-for-chronic-migraine-tips-and-tricks/30277/Ten Questions for Andrew M. Blumenfeld, MDToward Personalized Care for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/toward-personalized-care-for-multiple-sclerosis/31754/Biomarkers and precision medicine are just part of individualizing care for a diverse population of people with multiple sclerosis.New Guidelines for the Assessment of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/new-guidelines-for-the-assessment-of-traumatic-brain-injury/35727/Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, the University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testinYoung-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroAdult-Onset Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/adult-onset-cerebellar-ataxias/31221/Pravin Khemani, MD, Medical Director, Movement Disorders Program, Swedish Neuroscience Institute, provides a framework for evaluation of adult-onset cerebellar ataxias.ELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.A Mark of Success?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-mark-of-success/31075/Achim Schneeberger, MD, talks about the Phase II study that demonstrated clinical and biomarker effects consistent with disease modification in Alzheimer's. (headphones recommended)A Coming of Age for Neuroimmunology
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-coming-of-age-for-neuroimmunology/30122/Increasingly complex diagnostics and highly effective disease-modifying therapy come with challenges in clinical decision making.